The study met its key secondary endpoint, showing a statistically significant and clinically meaningful OS benefit with the Itovebi-based regimen compared with palbociclib and fulvestrant alone.

But the company is now jumping head-first into the AI space with the launch of an AI agent builder that combines large language models and the Postman API platform, as well as a visual editor that ...

The trial achieved primary endpoint by demonstrating a statistically significant and superior weight loss at week 72 with semaglutide 7.2 mg versus placebo. "We are very pleased to demonstrate 20. ...